The Next Generation Platform for the Biomanufacturing of Recombinant Therapeutics

ALGENICS is a privately-held biotechnology company focusing on innovative uses of microalgae to produce recombinant biotherapeutics.Our proprietary platform Algebiosys™ allows the biomanufacturing of a broad range of therapeutics in our PTA cell line including complex multimeric glycoproteins.

Latest News


Please enter your email address to receive the news

#
Be the first to get all the inside info